Form D — BioIntelliSense, Inc.
0001824134-25-000003 · filed Dec 19, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- Rule 506(b)
- Reported offering amount
- $58,350,027
- Reported amount sold
- $58,050,027
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- BioIntelliSense, Inc.
- CIK
- 1824134
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 17301 W. COLFAX AVENUE
GOLDEN, Colorado 80401 - Phone
- 720-689-9008
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Wang · Executive OfficerGolden, Colorado Find on LinkedIn ↗
-
James Mault · Executive OfficerGolden, Colorado Find on LinkedIn ↗
-
Conlan Ma · DirectorGolden, Colorado Find on LinkedIn ↗
-
Dawn Owens · DirectorGolden, Colorado Find on LinkedIn ↗
-
Xinyaun Yu · DirectorGolden, Colorado Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗